Aligos Therapeutics, Inc.
corporate_fare Company Profile
Aligos Therapeutics, Inc. (NASDAQ:ALGS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for ALGS at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Aligos Therapeutics Reports $1.91 Per Share Loss for Fourth Quarter
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$2.19M
Net Income
-$24.19M
Diluted EPS
-$2.45
Op. Cash Flow
-$82.5M
Operating Income
-$87.98M
Cash & Equivalents
$18.3M
Debt / Equity
0.00×
Net Margin
-11.07×
Shares Outstanding
6.18M sh
Source: 10-K · filed 2026-03-05 · accession 0001193125-26-092614
show_chartPrice Chart
Loading chart...
feed ALGS - Filings & News (Page 2)
ALGS
Mar 05, 2026, 8:00 AM EST
Price at Filing:
$7.20
Real-time Price:
$1.17
Change:
-$6.03 (-84%)
Market Cap:
$8.599M